Company / Operating Cash Flow per Share
Emergent BioSolutions Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$3.27
FY2025
5-year range
-$3.95 / $6.24
FY2021-FY2025
Trend
+202.9%
vs FY2024
Sector context
#32 of 212
Health Care
What the data says
Operating Cash Flow per Share changed +203% YoY in FY2025, a notable deviation from the 9-year average annual change of +32%.
Based on SEC 10-K filings.
3.27 in FY2025 with a 5-year CAGR of -20.6%. Top quartile in the Health Care sector.
Improved from $-3.95 to $3.27 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -20.6%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 212This company $3.27 Sector average -$14.72
▼
+122.2% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 202.9% year-over-year.
- Ranks #32 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2020.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.27 | +202.9% |
| FY2024 | $1.08 | +127.4% |
| FY2023 | -$3.95 | -494.6% |
| FY2022 | -$0.66 | -110.6% |
| FY2021 | $6.24 | -39.8% |
| FY2020 | $10.37 | +185.1% |
| FY2019 | $3.64 | +229.0% |
| FY2018 | $1.11 | -78.5% |
| FY2017 | $5.13 | +270.2% |
| FY2016 | $1.39 | +22.9% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026